This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by LITTLE, J. A. Articles by YANO, R. Search for Related Content PubMed PubMed Citation Articles by LITTLE, J. A. Articles by YANO, R.

(Circulation. 1965;31:854.)
© 1965 American Heart Association, Inc.

---

Studies of Male Survivors of Myocardial Infarction

IV. Serum Lipids and Five-Year Survival

J. ALICK LITTLE M.D.¹; HENRY M. SHANOFF M.D.¹; ROBERT D. ROE M.D.¹; ADELE CSIMA M.A.¹; RUTH YANO ¹

¹ From the Atherosclerosis Project, Sunnybrook (Department of Veterans Affairs) Hospital, and the Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

This study examined life expectancy and serum lipids in 120 men with atherosclerotic coronary heart disease. Five-year survival from onset of infarction was 79 per cent. No relationship could be demonstrated between survival and the level of the total serum cholesterol, Std. S_f 0-12, 12-20, 20-100, and 100-400 lipoproteins. Survival for patients with an infarct less than 6 months before entry into the study was shorter, despite serum lipid levels the same as the remainder of the group.

Although the age of onset of coronary disease is influenced by serum lipid levels, survival subsequent to infarction is not. This paradox suggests that serum lipids affect rate of atherogenesis in the long preclinical stage but in the short clinical stage other factors determine survival.